Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhi Zao Ju Rd., Shanghai, 200011, People's Republic of China.
Aesthetic Plast Surg. 2020 Oct;44(5):1516-1521. doi: 10.1007/s00266-020-01912-x. Epub 2020 Aug 13.
Polyacrylamide gel (PAAG) migration after esthetic breast injection is clinically variable and complex, and thus, the rate of incomplete removal after debridement is high.
We aimed to describe a practical classification system for PAAG migration after breast injection and evaluate the outcome of our management.
A retrospective review of medical records was conducted for patients who presented to our institution for the management of PAAG migration after injection augmentation mammaplasty from June 2013 to November 2018. PAAG migration was evaluated by MRI examination and classified based on the migrating direction outside the breast contour. Surgery was performed to remove the material completely through different incisions.
Seventy-eight women met the study criteria, with 106 breasts identified as showing PAAG migration. Patients were classified as having superior (22%), lateral (25%), inferior (34%), medial (10%) or complex (9%) PAAG displacement. The mean follow-up was 9 months (range 3-18 months). Postoperative complications included seroma (n = 3), delayed wound healing (n = 2), occasional breast pain (n = 5) and paresthesia or numbness at the migrated site (n = 2). MRI re-examination revealed that most of the injected material was removed, and no patient needed a secondary debridement operation.
PAAG migration after injection augmentation mammaplasty can be clinically characterized into different types based on the migrating direction. It is helpful to perform MRI examinations preoperatively to fully evaluate PAAG migration. Under the guidance of our classification system, the injected material could be effectively eradicated with an acceptable complication rate.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
美容乳房注射后聚丙酰胺凝胶(PAAG)的迁移具有临床多变性和复杂性,因此,清创后不完全清除的发生率很高。
我们旨在描述一种用于乳房注射后 PAAG 迁移的实用分类系统,并评估我们的管理结果。
对 2013 年 6 月至 2018 年 11 月因注射隆乳后 PAAG 迁移到我院就诊的患者进行病历回顾性研究。通过 MRI 检查评估 PAAG 迁移,并根据乳房轮廓外的迁移方向进行分类。通过不同的切口进行手术以完全清除材料。
78 名女性符合研究标准,共 106 只乳房被诊断为 PAAG 迁移。患者被分为上(22%)、外(25%)、下(34%)、内(10%)或复杂(9%)PAAG 移位。平均随访 9 个月(3-18 个月)。术后并发症包括血清肿(n=3)、伤口愈合延迟(n=2)、偶尔乳房疼痛(n=5)和迁移部位的感觉异常或麻木(n=2)。MRI 复查显示,大部分注射材料已被清除,无患者需要二次清创手术。
注射隆乳后 PAAG 迁移可根据迁移方向在临床上分为不同类型。术前进行 MRI 检查有助于全面评估 PAAG 迁移。在我们的分类系统指导下,可有效消除注射材料,并发症发生率可接受。
证据水平 III:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南 www.springer.com/00266 。